Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Merus N.V. CS (NQ: MRUS ) 49.66 -1.27 (-2.49%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Merus N.V. CS < Previous 1 2 3 Next > MRUS Stock Earnings: Merus Misses EPS, Misses Revenue for Q2 2024 August 01, 2024 MRUS stock results show that Merus missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. Via InvestorPlace Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 28, 2024 Via Benzinga Crude Oil Rises 1%; Verastem Shares Slide May 24, 2024 Via Benzinga Exposures Fossil Fuels Expert Ratings for Merus November 28, 2023 Via Benzinga The Latest Analyst Ratings for Merus October 24, 2023 Via Benzinga 10 Analysts Have This to Say About Merus September 14, 2023 Via Benzinga Where Merus Stands With Analysts August 10, 2023 Via Benzinga Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session May 24, 2024 Via Benzinga Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday? May 24, 2024 Merus announces interim clinical data on petosemtamab and Keytruda (pembrolizumab) for first-line recurrent/metastatic head and neck squamous cell carcinoma. Early results show promising efficacy with... Via Benzinga Nasdaq Gains 1%; Intuit Shares Plunge May 24, 2024 Via Benzinga Expert Ratings for Merus July 24, 2023 Via Benzinga Analyst Expectations for Merus's Future June 30, 2023 Via Benzinga Where Merus Stands With Analysts May 18, 2023 Via Benzinga Recap: Merus Q1 Earnings May 04, 2023 Via Benzinga Analyst Boosts Merus Price Target As AACR Updates Meaningfully De-Risk Its Head & Cancer Therapy April 18, 2023 Via Benzinga Why Top 4% Biotech Stock, Merus, Just Catapulted To A Record High May 24, 2024 The company passed investors' bar for success in a study of a head-and-neck cancer treatment. Via Investor's Business Daily Deckers Outdoor Posts Upbeat Earnings, Joins Guardant Health, Ross Stores And Other Big Stocks Moving Higher On Friday May 24, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday May 24, 2024 We're diving into the biggest pre-market stock movers that traders need to know about on Friday morning with all of the latest news! Via InvestorPlace MRUS Stock Earnings: Merus Beats EPS, Misses Revenue for Q1 2024 May 09, 2024 MRUS stock results show that Merus beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace The Latest Analyst Ratings for Merus April 05, 2023 Via Benzinga 4 Analysts Have This to Say About Merus March 01, 2023 Via Benzinga AstraZeneca's Tagrisso-Chemo Combo Data In Lung Cancer Sets High Bar For Johnson & Johnson's Cancer Drug: Analyst September 11, 2023 On Sunday night, AstraZeneca Plc (NASDAQ: AZN) presented the Phase 3 FLAURA2 results evaluating Tagrisso plus chemotherapy versus Tagrisso monotherapy as first-line treatment for patients Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 21, 2023 August 21, 2023 Via Benzinga 7 Stocks That Wall Street Analysts Are Loving in May May 21, 2023 Though not perfect, an analyst rating can indicate where institutional investor sentiment lies; here are seven stocks that analysts love. Via InvestorPlace Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday April 18, 2023 U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session. Via Benzinga Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 18, 2023 Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional... Via Benzinga Merus' Petosemtamab Abstract Hits Upside Scenario For Overall Response Rate, Duration Of Response: Analyst April 14, 2023 Via Benzinga What To Expect When Merus Presents Petosemtamab Data Update At AACR April 06, 2023 Via Benzinga The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector March 15, 2023 To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. Via InvestorPlace Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session February 09, 2023 Gainers Hempacco Co., Inc. (NASDAQ: HPCO) rose 296% to $2.99 after declining 6% on Wednesday. Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
